M6620 Plus Standard Treatment in Oesophageal and Other Cancer

NCT03641547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Oesophageal Adenocarcinoma
Squamous Cell Carcinoma
Solid Tumor

Interventions

DRUG: M6620
DRUG: Cisplatin
DRUG: Capecitabine
RADIATION: Radiotherapy

Sponsor

University of Oxford

Collaborators

[object Object]